Parkman Healthcare Partners LLC trimmed its holdings in shares of Oscar Health, Inc. (NYSE:OSCR - Free Report) by 50.0% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 125,000 shares of the company's stock after selling 125,000 shares during the period. Parkman Healthcare Partners LLC owned about 0.05% of Oscar Health worth $1,680,000 at the end of the most recent reporting period.
Other large investors have also modified their holdings of the company. Summit Investment Advisors Inc. increased its stake in Oscar Health by 5.8% in the 4th quarter. Summit Investment Advisors Inc. now owns 20,838 shares of the company's stock valued at $280,000 after purchasing an additional 1,141 shares in the last quarter. Arizona State Retirement System grew its holdings in Oscar Health by 3.1% during the 4th quarter. Arizona State Retirement System now owns 47,918 shares of the company's stock valued at $644,000 after buying an additional 1,454 shares during the last quarter. Xponance Inc. grew its holdings in Oscar Health by 12.9% during the 4th quarter. Xponance Inc. now owns 14,394 shares of the company's stock valued at $193,000 after buying an additional 1,649 shares during the last quarter. KBC Group NV grew its holdings in Oscar Health by 56.1% during the 4th quarter. KBC Group NV now owns 7,107 shares of the company's stock valued at $96,000 after buying an additional 2,555 shares during the last quarter. Finally, Alliancebernstein L.P. grew its holdings in Oscar Health by 1.1% during the 4th quarter. Alliancebernstein L.P. now owns 243,160 shares of the company's stock valued at $3,268,000 after buying an additional 2,600 shares during the last quarter. 75.70% of the stock is owned by hedge funds and other institutional investors.
Insider Buying and Selling at Oscar Health
In other Oscar Health news, Director Elbert O. Jr. Robinson sold 25,000 shares of Oscar Health stock in a transaction that occurred on Monday, May 12th. The stock was sold at an average price of $16.43, for a total value of $410,750.00. Following the completion of the transaction, the director now directly owns 64,512 shares in the company, valued at $1,059,932.16. The trade was a 27.93% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link. 24.39% of the stock is currently owned by corporate insiders.
Analyst Upgrades and Downgrades
Separately, Wells Fargo & Company cut Oscar Health from an "overweight" rating to an "equal weight" rating and lowered their target price for the company from $20.00 to $16.00 in a report on Thursday, March 13th. Two investment analysts have rated the stock with a sell rating, two have issued a hold rating, two have issued a buy rating and one has assigned a strong buy rating to the company's stock. Based on data from MarketBeat.com, the stock has a consensus rating of "Hold" and an average target price of $20.08.
Get Our Latest Analysis on OSCR
Oscar Health Trading Down 3.6%
Shares of OSCR traded down $0.63 during trading hours on Monday, hitting $16.89. The stock had a trading volume of 3,332,192 shares, compared to its average volume of 4,195,901. The company has a debt-to-equity ratio of 0.26, a quick ratio of 0.73 and a current ratio of 0.73. The firm has a market cap of $4.23 billion, a P/E ratio of -844.33 and a beta of 1.75. The company's fifty day simple moving average is $13.46 and its 200 day simple moving average is $14.63. Oscar Health, Inc. has a 12-month low of $11.20 and a 12-month high of $23.79.
Oscar Health (NYSE:OSCR - Get Free Report) last released its quarterly earnings data on Wednesday, May 7th. The company reported $0.92 EPS for the quarter, beating the consensus estimate of $0.83 by $0.09. Oscar Health had a return on equity of 2.28% and a net margin of 0.28%. The company had revenue of $3 billion for the quarter, compared to analyst estimates of $2.87 billion. During the same period last year, the company posted $0.62 earnings per share. The firm's revenue was up 42.2% compared to the same quarter last year. Equities research analysts forecast that Oscar Health, Inc. will post 0.69 EPS for the current fiscal year.
About Oscar Health
(
Free Report)
Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.
See Also
Before you consider Oscar Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Oscar Health wasn't on the list.
While Oscar Health currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
